Virus Promising in Treatment of Neuroendocrine Cancers - Small-cell lung cancer and other tumors destroyed without risk of inhibition by human blood - RNweb

Nursing

Powered By Nursing
Virus Promising in Treatment of Neuroendocrine CancersSmall-cell lung cancer and other tumors destroyed without risk of inhibition by human blood

Source: RN

A newly discovered picornavirus has been shown to have potential as a potent cytolytic agent in cell lines with neuroendocrine properties, including small-cell lung cancer and retinoblastoma, according to a report published in the Nov. 7 issue of the Journal of the National Cancer Institute.

P. Seshidhar Reddy, of Neotropix Inc., in Malvern, Pa., and colleagues tested the oncolytic efficacy of the virus, Seneca Valley Virus-001 (SVV-001), in tumor and normal cell lines using in vitro cytotoxicity assays. Blood inactivation assays were conducted to assess suitability of the virus for intravenous delivery. In vivo assessment of intravenous-delivered SVV-011 was tested on immune-competent A/J mice and athymic mice bearing pre-established tumors.

A variety of tumor cell lines with neuroendocrine properties were sensitive to SVV-001, with small-cell lung cancers and solid pediatric cancers demonstrating a sensitivity at least 10,000 times that of the adult normal human cells tested. No deleterious effect on normal cells was observed. Hemagglutination, whole-blood inactivation, and neutralization assays show no evidence of virus inactivation in the blood. No dose-limiting toxicity was observed in the immune-competent mice, and injections of SVV-001 resulted in eradication of all small-cell lung cancer tumors and a majority of retinoblastoma tumors in the athymic mice.

"These attributes lend promise of this agent for the treatment of small-cell lung cancer and other cancers with neuroendocrine properties," the authors conclude.

Reddy and several co-authors of this study work for and have a financial interest in Neotropix, Inc., which seeks to develop SVV-001 as a treatment for cancer.

Abstract

Full Text


Prepared jointly by the editors of RN and HealthDay's Physicians' Briefing (www.physiciansbriefing.com).

Other Articles from RN
Comorbidities Worsen Fatigue in HIV-Positive Patients
Drugs Can Slow Lung Function Decline in Pulmonary Disease
More U.S. Women Using Contraceptive Services
Gender Differences Identified in Asthma Pathogenesis
Drugs Can Slow Lung Function Decline in Pulmonary Disease
Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here

RN
Stay Connected to RNIssue Archive
Subscribe to Enewsletter


Source: RN,
Click here